| Line item | 2025-10-31 FY | 2024-10-31 FY | 2023-10-31 FY | 2022-10-31 FY | 2021-10-31 FY |
|---|---|---|---|---|---|
| Revenue | $2.55M | $2.56M | $2.37M | $2.16M | $1.83M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $2.56M | $2.50M | $2.49M | $2.22M | $1.99M |
| R&D | – | – | – | – | – |
| SG&A | $694.66K | $663.71K | $585.65K | $503.96K | $871.55K |
| Operating Income | -$6.49K | $58.70K | -$117.94K | -$60.45K | -$155.76K |
| Interest Expense | – | – | – | – | – |
| Tax Expense | -$24.93K | -$26.13K | -$29.90K | -$38.74K | – |
| Net Income | $35.35K | $99.09K | -$97.87K | $32.76K | -$163.59K |
| EPS (basic) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | – |
| EPS (diluted) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | – |
| Shares (diluted) | $59.77M | $61.22M | $53.14M | $58.83M | – |